Q1 EPS Estimates for Henry Schein Cut by Zacks Research

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Zacks Research dropped their Q1 2025 EPS estimates for Henry Schein in a report released on Tuesday, March 18th. Zacks Research analyst R. Department now expects that the company will earn $1.11 per share for the quarter, down from their prior estimate of $1.17. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein’s Q2 2025 earnings at $1.21 EPS, Q3 2025 earnings at $1.26 EPS, Q4 2025 earnings at $1.26 EPS, FY2025 earnings at $4.84 EPS, Q1 2026 earnings at $1.32 EPS, Q2 2026 earnings at $1.36 EPS, Q3 2026 earnings at $1.25 EPS, Q4 2026 earnings at $1.39 EPS, FY2026 earnings at $5.31 EPS and FY2027 earnings at $5.74 EPS.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the company earned $0.66 EPS.

Several other brokerages have also recently weighed in on HSIC. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Mizuho began coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target for the company. Wells Fargo & Company initiated coverage on Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective on the stock. Jefferies Financial Group raised their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Finally, UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Stock Performance

NASDAQ HSIC opened at $70.84 on Thursday. The stock has a market capitalization of $8.80 billion, a PE ratio of 29.15, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein has a 1-year low of $63.67 and a 1-year high of $82.49. The business has a 50 day simple moving average of $74.84 and a two-hundred day simple moving average of $72.62. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Hedge Funds Weigh In On Henry Schein

A number of hedge funds have recently added to or reduced their stakes in HSIC. Wealth Enhancement Advisory Services LLC raised its position in Henry Schein by 34.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 52,891 shares of the company’s stock valued at $3,660,000 after purchasing an additional 13,431 shares in the last quarter. Siemens Fonds Invest GmbH lifted its stake in Henry Schein by 282.3% in the fourth quarter. Siemens Fonds Invest GmbH now owns 13,366 shares of the company’s stock worth $925,000 after acquiring an additional 9,870 shares during the period. Menard Financial Group LLC bought a new position in Henry Schein during the 4th quarter worth about $92,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Henry Schein during the 4th quarter valued at about $5,743,000. Finally, Jefferies Financial Group Inc. raised its holdings in shares of Henry Schein by 98.8% in the 4th quarter. Jefferies Financial Group Inc. now owns 83,100 shares of the company’s stock valued at $5,751,000 after purchasing an additional 41,300 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.